Faculty of Clinical Pharmacy
Faculty of Clinical Pharmacy , WAPCP
Chairman
Prof Noel N. Wannang, B.Pharm., M.Sc (P’cology)., PhD (P’cology and Clinical Pharmacy)., M.Sc (Biochemistry)., LLB., BL., Cert (Leadership)., PGDE., FPCPharm (Clinical Pharmacy), FWASP., fhCD., FPSN., FNAPharm.
Professor of Pharmacology and Toxicology, University of Jos
Phone: +234 8037877988
Email: nnwannang1@yahoo.com, wannangn@unijos.edu.ng
Vice Chairman
Dr Michael Lahai
FPCPharm. (Clin Pharm), MSc. (Pharm Chem), PhD (In view), PharmD., BPharm. (Hons)
Head of Quality Assurance, Pharmacy Board of Sierra Leone.
Chairman for Research, Innovation and Publication, Faculty of Pharmacy College of Medicine and Allied Health Sciences.
Chairman, Faculty of Clinical Pharmacy, Sierra Leone Postgraduate College of Pharmacists.
Phone No.: +232 76395050
Email: miclahisaac@gmail.com
Secretary :
Dr Chinenye I. Onodugo, B.Pharm., Pharm D., M.Pharm. (Clinical Pharmacy and Pharmacy Management), PhD (Clinical Pharmacy), FPCPharm (Clinical Pharmacy)
Deputy Director of Pharmacy (Accident & Emergency/ Budget & Planning Unit) Pharmacy Department, University of Nigeria Teaching Hospital Ituku Ozalla, Enugu Nigeria
Phone: +234 8035681385
Email: chifydugo@gmail.com
FACULTY OF
CLINICAL PHARMACY
PART ONE
|
S/N |
CODE |
TITLE |
CONTENT |
UNITS |
|
1 |
PCP 101 |
Pharmaceutical
Care I |
Data
collection and evaluation, drug therapy problems, Development, Implementation
and Monitoring of care plans. |
2 |
|
2 |
PCP 102 |
Pharmacy
Management |
Functions
of management, human resources management, Financial and time management,
Leadership, Management tools and their application to pharmacy |
6 |
|
3 |
PCP 103 |
Inferential
Biostatistics |
Hypothesis
testing, exploring differences between groups, t-test paired and unpaired, ANOVA, and their non parametric
equivalents (Mann Whitney test, Kruskal Wallis etc), student t-test, exploring relationships:
Pearson’s correlation, Chi squared test. Making predictions: regression;
factor analysis. Biocomputation and use of statistical packages. |
6 |
|
4 |
PCP 104 |
Research
Methodology I |
Conceiving
(characteristic and development) research, literature search, study design,
systematic reviews and meta analysis. project/research management,
referencing, proposal writing. |
6 |
|
5 |
PCP 105 |
Advanced
Communication Skills |
Cross cultural communications;
Emphatic listening; Assertiveness; Perception and its role in communication;
Conflict management; Interview techniques and Skills; Negotiation skills;
Advocacy skills and practices; Public education techniques and skills; Public
speaking; Writing skills; Communication strategies across diverse audiences; Communication
program models; Evaluation techniques for communication programs in health
and pharmacy. |
4 |
|
6 |
PCP 111 |
Pathophysiology
& Therapeutics I |
Pathophysiology
and Pharmacotherapy of: Diabetes Mellitus, Hypertension, Congestive Cardiac Failure,
Acute Myocardial Infarction, Renal failure |
8 |
|
7 |
PCP 112 |
Pathophysiology
& Therapeutics II |
Pathophysiology
and Pharmacotherapy of: Peptic Ulcer Disease, asthma, Chronic Obstructive Pulmonary
Disease, Anaemia, Oncology. |
8 |
|
8 |
PCP 213 |
Clinical
Pharmacokinetics |
Clinical
significance of Pharmacokinetic Parameters, Dosage design and adjustment, Therapeutic
Drug Monitoring and Drug Interactions. |
4 |
|
9 |
PCP 214 |
Pharmacoepidemiology
/ Pharmacovigilance |
Concept and Principles of Pharmacoepidemiology;
Pharmacovigilance (ADR
and causal assessment, management and treatment of ADRs); Medical Surveillance and outbreak of diseases;
Risk Assessment; Screening and diagnostic testing; Post-marketing
surveillance; Data systems for pharmacoepidemiology studies; Visit to centers
for experiential learning. |
4 |
|
10 |
PCP 215 |
Pharmacoeconomics |
Basic
pharmacoeconomic Concepts, Pharmacoeconomics as a tool for making choices,
Pharmacoeconomic Evaluation Methods: Cost
minimization analysis, Cost benefit analysis, Cost utility analysis, Cost
effectiveness analysis, Direct and indirect health costs, Quality of life
evaluation, Applications of pharmacoeconomics |
4 |
|
11 |
PCP 216
|
Formulary Management and Drug Utilization Review |
Concepts in Development and Management of
Formularies; Program Medicine; Medicines and Therapeutic Committee
Activities: Identification of
regimen, Selection of Specific Drugs, Provision of the right information,
Administration/Consumption of Drug; Drug Use Evaluation, Monitoring
effectiveness, Education and Evaluation; Drug Utilization Review |
4 |
|
12 |
PCP
200 |
Seminar |
Presentation
on selected topics
|
4 |
|
13 |
PCP 201 |
Residency
I |
Experiential
Learning |
4* |
|
Total |
64 |
|||
*1
unit is equivalent to 8 hours of experiential learning
PART
TWO
|
S/N |
CODE |
COURSE |
CONTENT |
UNITS |
|
1 |
PCP 301 |
Research
Methodology II |
Measurements,
Experimental/Questionnaire design, sample size, methods and techniques, data
analysis, result presentation, discussion and conclusion. Report writing |
4 |
|
2 |
PCP 311 |
Clinical
Trials |
Scope,
Concept and Experimental design, Phases (practical examples), monitoring and
evaluation, documentations |
4 |
|
3 |
PCP 312 |
Patient
Assessment for Pharmacists |
Health/medical
terms, Techniques of assessment, diagnosis, Laboratory parameters
(blood, urine, microbiology etc), Point of Care testing; interpretation
of lab results; patient clerking, assessment & interview; patient
referral system; Hands on training |
6 |
|
Sub
Specialities |
|
|
||
|
4 |
PCP 411 |
Pharmaceutical
care and Therapeutic case studies I |
Cardiovascular,
Endocrine and Renal Disorders |
10 |
|
5 |
PCP 412 |
Pharmaceutical
care and Therapeutic case studies II |
Respiratory
and ENT Disorders |
10 |
|
6 |
PCP 413 |
Pharmaceutical care and
Therapeutic case studies III |
Gastrointestinal
and Nutritional Disorders |
10 |
|
7 |
PCP 414 |
Pharmaceutical
care and Therapeutic case studies IV |
Oncology
and Haematology Disorders |
10 |
|
8 |
PCP 415 |
Pharmaceutical
care and Therapeutic case studies V |
Mental
Health Disorders |
10 |
|
9 |
PCP 416 |
Pharmaceutical
care and Therapeutic case studies VI |
Critical
care |
10 |
|
10 |
PCP 417 |
Pharmaceutical
care and Therapeutic case studies VII |
Paediatrics |
10 |
|
11 |
PCP 400 |
Seminar |
Presentation
on selected topics |
4 |
|
12 |
PCP 401 |
Residency
II (Sub-specialty) |
Experiential
Learning |
30* |
|
13 |
PCP 402 |
Dissertation
(Sub-specialty) |
Research
Work |
12 |
|
Total
|
80 |
|||
*1
unit is equivalent to 8 hours of experiential learning
ANNUAL REPORT OF THE FACULTY OF CLINICAL PHARMACY, WAPCP AUGUST, 2024
1.0 INTRODUCTION
The Faculty of Clinical Pharmacy has been involved in a lot of activities intended to improve our curriculum, enhance specialization and provide continuing professional development to our members and all other interested colleagues.
2.0. OFFICERS
The officers of the Faculty are:
Chairman: Professor Noel N. Wannang, FPCPharm (Nigeria)
Vice Chairman: Dr Michael Lahai, FPCPharm (Sierra Leone)
Secretary: Dr (Mrs) Chinenye Onodugo, FPCPharm (Nigeria)
3.0 FACULTY MEETINGS
The Faculty held a virtual meeting on August 21, 2023 which was graced by the erstwhile President of the College Prof Cecilia Igwilo and attended by Two hundred and Fourteen (214) fellows and students of the Faculty from all the member countries. At the end of the meeting, the attendees noted that there is need for the Faculty/College to do more to enable recognition of the fellowship especially in pharmacist- dominated Institutions. They also commended the faculty on her training workshops which has helped built capacity in many areas of Clinical Pharmacy Practice. They also requested that more of such workshops be held. One of the attendees from Gambia shared challenges experienced (lack of mentorship and structured program for Residents) by College students in their residency training in Gambia and requested assistance from the College to overcome them.
The Faculty also held a physical meeting at the 2024 AGM in Gambia in which a robust discussion was held on the menace of illicit drug abuse in the sub-region. A working committee was set up to spearhead research in this area with a view to presenting solutions to this challenge. The Committee was given 3 months (till August, 2024) to submit its reports.
4.0 ACADEMIC AND RESEARCH ACTIVITIES
I. International Pharmacy Practice Residency (IPPR): As reported last year, the Faculty is still in top collaborating with ASHP (American Society of Health-system Pharmacists) on the International Pharmacy Practice Residency training in Delta State University Teaching Hospital (DELSUTH). The collaboration is progressing well and a new batch of residents have joined the program. We are immensely grateful to Dr. Teresa Pounds for her pivotal role in this program. The Faculty sent the newly approved Residency manual to the ASHP for their necessary action.
II. Residency Manual Development: To meet up with best global practices, the Faculty has developed a robust and standard Residency manual (Specialty based). Our Faculty-specific Specialty -based residency manual has been presented to the Harmonization Committee and in turn presented to the Council. The Council has approved the Residency manual as an official document of the College. The Faculty appreciates all the contributors for the difficult, herculean and time consuming task and for their time and intellectual contributions. Council has asked the Faculty to help other Faculties in the development of their manual using the Clinical Pharmacy as the template.
III. SOPs Development for Fellows: The Faculty has initiated a 10-man Team to develop the Standard Operating Procedures (SOPs) for our Fellows. This will facilitate, in no small measures, the bottlenecks in our Government hospitals and will serve as a guide for our Fellows at places of practice. We want to assure JFB that once this is concluded, it will serve as a template for other Faculties, just as the Residency manual program. However, the Faculty shall need to be financially assisted by the College in the development of this all important document
IV. 2023 November Examinations: At the November 2023 examinations, the Faculty recorded passes as follows:
Part One-58
Part Two-46
Specialisations
ü Cardiology/Endocrinology/Renal-32
ü Infectious Disease-11
ü Mental & Behavioral health-01
ü Oncology-02
We look forward to better performance this year.
5.0. WORKSHOPS AND SEMINARS ORGANIZED BY THE FACULTY
The Faculty hosted three series of practical, skill based and impactful workshops on different areas of Clinical Pharmacy practice as training tools as well as continuing education vehicles. Each workshop was executed entirely with funds raised from registration fees paid by participants.
The Faculty appreciates the overwhelming support she has received from members in executing these workshops especially in light of current economic realities.
The workshops were as follows:
1. Hands on workshop on Parenteral Drug Administration and Basic Life Support which successfully held in two parts: virtually prior to the CPAN (Clinical Pharmacists Association of Nigeria) conference and the hands on sessions held within the conference in Lagos, Lagos State (Nigeria) from 23-27th April, 2024. Feedback from the participants indicate that the trainings were practical and impactful. The Faculty collaborated with CPAN on this. Participants came from North Africa including some French speaking countries
2. Workshop on Mental Health initiatives for Pharmacists which held virtually from 3rd to 5th October, 2023. The Attendance to this was not optimal but we received positive feedback from those who took part in the workshop.
We look forward to seeing the outcomes of these trainings in improved clinical practice and enhanced service delivery from our colleagues.
6.0. EVENTS AND COLLABORATIONS
A. Annual Faculty Lecture: The Faculty hosted the second Faculty of Clinical Pharmacy Annual Lecture virtually on Tuesday, 5th December, 2023. The topic was “Pharmacy 2.0: Revolutionizing Practice in Resource Limited Settings” and the speaker was “Dr Paul Agbulu, a Nigerian Pharmacist in Diaspora. The lecture which was open to all pharmacists was very well attended and we have received positive feedback from attendees. The Faculty appreciates Dr Agbulu for the interesting and brilliant delivery. We hope members will be encouraged to be part of the 2024 edition which will hold on Tuesday, 3rd December, 2024. Other details will be communicated in due course.
B. Past Collaborations: In the past year, the Faculty collaborated with
i. Oncology Pharmacists Association of Nigeria (OPAN) and organized a training workshop that had over 100 participants. The topics were designed to meet up with the ever changing professional challenges.
ii. Clinical Pharmacists Association of Nigeria (CPAN) and organized a training workshop on Parenteral Drug Administration and Basic Life Support (BLS). The European Resuscitation Centre (ERC) providing the resource persons for BLS offered their certification for participants as an added certification. It was a hands on training, with over 140 participants (some from East/Central Africa)
C. Current Collaborations: This year, we collaborated with several bodies such as the Clinical Pharmacists Association of Nigeria (CPAN) and our sister Faculties in the College to organize training programs for pharmacists.
i. The Faculty jointly hosted workshops on Basics of X-ray/ECG/Ultrasound scan interpretation; First Aid and Immunization/parenteral drugs administration during the Second CPAN National Conference held at Lagos in April, 2024.
ii. We collaborated with the Faculty of Drug Production and Quality Control to host a workshop on Quality Control of medications, but couldn’t hold due to some truncation in Nigeria as a result of national protests and instability in the country.
iii. Faculty of Clinical Pharmacy workshop 3 will hold in October 2024 in collaboration with Oncology Pharmacy Practitioners Association of Nigeria (OPPAN). We encourage everyone to plan to attend. It promises to be a very informative and practical workshop.
7.0 ACHIEVEMENTS AND AWARDS
As a Faculty, we have been able to increase the sustained interest of pharmacists across the sub-region in continuing professional development and plan to continue to do so. The first recipients from the Faculty have been identified for the awards.
8.0. CHALLENGES
Our major challenge as a Faculty is paucity of funds for our various programs and events.
9.0 CONCLUSION AND FUTURE PLANS
The Faculty is assiduously working to consolidate the existing 5 areas of specialization and proposes to present a request to increase the areas of specialization from five (5) to seven (7) by including the ENT/Respiratory & Paediatric Pharmacy Specialties.
In addition, The Faculty has introduced critical care/specialized Nutrition specialties from Part One in order to improve enrolment in the said area.
We wish to appreciate the warm support and collaboration we have enjoyed from the College Management and Administration and hope to continually improve the quality of our trainees and Fellows. We also welcome constructive feedback and suggestions from our students and Fellows. Together, we can!.
Prof NN Wannang Dr C Onodugo
(Chairman) (Secretary)